What we learned this week
Plenty.
We learned that being "trapped" in a position is a good thing.
We learned that Insmed DID NOT do a nine month dog toxicity study..... just for the fun of it. The FDA asked them to. This bit of information was worthy of being called the post of the day, and was posted and reposted several times.
We learned that institutional owners of securities are insiders.
We learned that if only Insmed had contacted a single poster instead of professional consultants, they would be gearing up to sell iplex to MMD patients right now.
We learned that if four individuals post during the same hour, they are the same person.
Who ever said that stock message boards are not a valuable tool?